Synthesis and evaluation of insulin-human serum albumin conjugates

Bioconjugate Chemistry

Volumn 16, Issue 4, 2005, Pages 1000-1008

  Thibaudeau, Karen ^a   Léger, Roger ^a   Huang, Xicai ^a   Robitaille, Martin ^a   Quraishi, Omar ^a   Soucy, Chantal ^a   Bousquet Gagnon, Nathalie ^a   Van Wyk, Pieter ^a   Paradis, Véronique ^a   Castaigne, Jean Paul ^a   Bridon, Dominique ^a  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSYNTHESIS; BODY FLUIDS; GLUCOSE;

AMINO GROUP; AQUEOUS MEDIA; HUMAN INSULINS; HUMAN SERUM ALBUMINS; IN-VITRO; MALEIMIDES; RECEPTOR ACTIVATION; RECEPTOR BINDING; STRUCTURE-ACTIVITY RELATIONSHIPS; SYNTHESISED;

INSULIN;

HUMAN SERUM ALBUMIN; INSULIN RECEPTOR; MALEIMIDE DERIVATIVE; RECOMBINANT HUMAN INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHEMICAL STRUCTURE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG CONJUGATION; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE RECEPTOR INTERACTION; INSULIN TREATMENT; MASS SPECTROMETRY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; STREPTOZOCIN DIABETES; SYNTHESIS; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 22644432886     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc050102k     Document Type: Article

References (37)

1. Hirsch, I. B. (2005) Insulin analogues. N. Engl. J. Med. 352, 174-183.
2. Lindholm, A. (2002) New insulins in the treatment of diabetes mellitus. Best Pract. Res. Clin. Gastroenterol. 16, 475-492.
3. Gerich, J. E. (2002) Novel insulins: expanding options in diabetes management. Am. J. Med. 113, 308-316.
4. Gerich, J. E. (2004) Insulin glargine: long-acting basal insulin analogue for improved metabolic control. Curr. Med. Res. Opin. 20, 31-37.
5. Barlocco, D. (2003) Insulin detemir. Novo Nordisk. Curr. Opin. Investig. Drugs 4, 449-454.
6. Kurtzhals, P., Havelund, S., Jonassen, I., Kiehr, B., Ribel, U., and Markussen, J. (1996) Albumin binding and time action of acylated insulins in various species. J. Pharm. Sci. 85, 304-308.
7. Kurtzhals, P., Havelund, S., Jonassen, I., Kiehr, B., Larsen, U. D., Ribel, U., and Markussen, J. (1995) Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo. Biochem. J. 312, 725-731.
8. Dea, M. K., Hamilton-Wessler, M., Ader, M., Moore, D., Schaffer, L., Loftager, M., Vølund, A., and Bergman, R. N. (2002) Albumin binding of acylated insulin (NN304) does not deter action to stimulate glucose uptake. Diabetes 51, 762-769.
9. Hamilton-Wessler, M., Ader, M., Dea, M. K., Moore, D., Loftager, M., Markussen, J., and Bergman, R. N. (2002) Mode of transcapillary transport of insulin and insulin analog NN304 in dog hind limb: evidence for passive diffusion. Diabetes 51, 574-582.
10. Tsai, Y. J., Rottero, A., Chow, D. D., Hwang, K. J., Lee, V. H. L., Zhu, G., and Chan, K. K. (1997) Synthesis and purification of NB1-palmitoyl insulin. J. Pharm. Sci. 86, 1264-1268.
11. Hashimoto, M., Takada, K., Kiso, Y., and Muranishi, S. (1989) Synthesis of palmitoyl derivatives of insulin and their biological activities. Pharm. Res. 6, 171-176.
12. Nakashima, K., Miyagi, M., Goto, K., Matsumoto, Y., and Ueoka, R. (2004) Enzymatic and hyperglycemia stability of chemically modified insulins with hydrophobic acyl groups. Bioorg. Med. Chem. Lett. 14, 481-483.
13. Hinds, K. D., and Kim, S. W. (2002) Effects of PEG conjugation on insulin properties. Adv. Drug Delivery Rev. 54, 505-530.
14. Hinds, K., Koh, J. J., Joss, L., Liu, F., Baudyš, M., and Kim, S. W. (2000) Synthesis and characterization of poly(ethylene glycol)-insulin conjugates. Bioconjugate Chem. 11, 195-201.
15. Baudyš, M., Letourneur, D., Liu, F., Mix, D., Jozefonvicz, J., and Kim, S. W. (1998) Extending insulin action in vivo by conjugation to carboxymethyl dextran. Bioconjugate Chem. 9, 176-183.
16. Chuang, V. T. G., Kragh-Hansen, U., and Otagiri, M. (2002) Pharmaceutical strategies utilizing recombinant human serum albumin. Pharm. Res. 19, 569-577.
17. Léger, R., Thibaudeau, K., Robitaille, M., Quraishi, O., van Wyk, P., Bousquet-Gagnon, N., Carette, J., Castaigne, J.-P., and Bridon, D. P. (2004) Identification of CJC-1131-albumin bioconjugate as a stable and bioactive GLP-1(7-36) analog. Bioorg. Med. Chem. Lett. 14, 4395-4398.
18. Léger, R., Benquet, C., Huang, X., Quraishi, O., van Wyk, P., and Bridon, D. (2004) Kringle 5 peptide-albumin conjugates with anti-migratory activity. Bioorg. Med. Chem. Lett. 14, 841-845.
19. Léger, R., Robitaille, M., Quraishi, O., Denholm, E., Benquet, C., Carette, J., van Wyk, P., Pellerin, I., Bousquet-Gagnon, N., Castaigne, J.-P., and Bridon, D. P. (2003) Synthesis and in vitro analysis of atrial natriuretic peptide-albumin conjugates. Bioorg. Med. Chem. Lett. 13, 3571-3575.
20. Kratz, F., Warnecke, A., Scheuermann, K., Stockmar, C., Schwab, J., Lazar, P., Drückes, P., Esser, N., Drevs, J., Rognan, D., Bissantz, C., Hinderling, C., Folkers, G., Fichtner, I., and Unger, C. (2002) Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound. J. Med. Chem. 45, 5523-5533.
21. Holmes, D. L., Thibaudeau, K., L'Archeveque, B., Milner, P. G., Ezrin, A. M., and Bridon, D. P. (2000) Site specific 1:1 opioid:albumin conjugate with in vitro activity and long in vivo duration. Bioconjugate Chem. 11, 439-444.
22. Duttaroy, A., Kanakaraj, P., Osborn, B. L., Schneider, H., Pickeral, O. K., Chen, C., Zhang, G., Kaithamana, S., Singh, M., Schulingkamp, R., Crossan, D., Bock, J., Kaufman, T. E., Reavey, P., Carey-Barber, M., Krishnan, S. R., Garcia, A., Murphy, K., Siskind, J. K., McLean, M. A., Cheng, S., Ruben, S., Birse, C. E., and Blondel, O. (2005) Development of a long-acting insulin analog using albumin fusion technology. Diabetes 54, 251-258.
23. Xia, C. Q., Wang, J., and Shen, W. C. (2000) Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats. J. Pharmacol. Exp. Ther. 295, 594-600.
24. Keller, O., and Rudinger, J. (1975) Preparation and some properties of maleimido acids and maleoyl derivatives of peptides. Helv. Chim. Acta. 58, 531-541.
25. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
26. Huang, K., Xu, B., Hu, S. Q., Chu, Y. C., Hua, Q. X., Qu, Y., Li, B., Wang, S., Wang, R. Y., Nakagawa, S. H., Theede, A. M., Whittaker, J., De Meyts, P., Katsoyannis, P. G., and Weiss, M. A. (2004) How insulin binds: the B-chain alpha-helix contacts the L1 beta-helix of the insulin receptor. J. Mol. Biol. 341, 529-550.
27. Hansen, L. B. Selective Acylation Method. US 5,905,140 (May 18, 1999).
28. Gao, J., Mrksich, M., Gomez, F. A., and Whitesides, G. M. (1995) Using capillary electrophoresis to follow the acetylation of the amino groups of insulin and to estimate their basicities. Anal. Chem. 67, 3093-3100.
29. Glattahard, R., and Matter, M. (1963) Neues, mildes verfahren zur Herstellung von aktiven carbonsäure-estern und deren Verwendung als acylierungsmittel. Helv. Chim. Acta 46, 795-804.
30. Kim, S., Lee, J. I., and Kim, Y. C. (1985) A simple and mild esterification method for carboxylic acids using mixed carboxylic-carbonic anhydrides. J. Org. Chem. 50, 560-565.
31. Liu, F., Song, S. C., Mix, D., Baudys, M., and Kim, S. W. (1997) Glucose-induced release of glycosylpoly(ethylene glycol) insulin bound to a soluble conjugate of concanavalin A. Bioconjugate Chem. 8, 664-672.
32. Markussen, J., Halstrom, J., Wiberg, F. C., and Schaffer, L. (1991) Immobilized insulin for high capacity affinity chromatography of insulin receptors. J. Biol. Chem. 266, 18814-18818.
33. Losse, G., Naumann, W., and Raddatz, H. (1983) Untersuchungen zur tert-butyloxycarbonylferung von insulin. Z. Chem. 23, 22-23.
34. Losse, G., and Richler, B. (1981) Darstellung von B1-Boc-und B29-Boc-insulin-B-Ketten-di-S-sulfonat. Z. Chem. 21, 70-71.
35. De Meyts, P., and Whittaker, J. (2002) Structural biology of insulin and IGF1 receptors: implications for drug design. Nat. Rev. Drug Discovery 1, 769-783.
36. Koch, R., and Weber, U. (1981) Partial purification of the solubilized insulin receptor from rat liver membranes by precipitation with concanavalin A. Hoppe Seylers Z. Physiol. Chem. 362, 347-351.
37. Moody, A. J., Stan, M. A., Stan, M., and Gliemann, J. (1974) A simple free fat cell bioassay for insulin. Horm. Metab. Res. 6, 12-16.